Study on the status quo and correlation between body image and stigma of drug-resistant tuberculosis patients treated with Clofazimine
10.3760/cma.j.cn211501-20220411-01103
- VernacularTitle:含氯法齐明方案治疗的耐药肺结核患者身体意象与病耻感现状及其相关性研究
- Author:
Fanghui XIE
1
;
Limei LEI
;
Rong YAO
;
Xia ZHAO
;
Bin WAN
;
Meng MENG
Author Information
1. 成都市公共卫生临床医疗中心结核二病区，成都 610061
- Keywords:
Tuberculosis;
Drug tolerance;
Clofazimine;
Body image;
Stigma;
Relevance
- From:
Chinese Journal of Practical Nursing
2023;39(7):486-491
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the current situation of body image and stigma of drug-resistant tuberculosis patients treated with Clofazimine, and analyze the correlation between them.Methods:A cross-sectional study was conducted using convenience sampling method to investigate 150 patients with drug-resistant tuberculosis treated with Clofazimine in tuberculosis ward of Chengdu Public Health Clinical Medical Center from October 2020 to October 2021. The general questionnaire, Body Image Scale (BIS) and Tuberculosis Related Stigma Scale were used to conduct a questionnaire survey.Results:A total of 130 questionnaires were effectively collected. The body image score of 130 patients with drug-resistant tuberculosis treated with Clofazimine was (20.51 ± 6.80) points; the score of stigma was (17.78 ± 6.92) points. There was a positive correlation between the total score of disease shame and the total score of body image ( r=0.544, P<0.05). Conclusions:Patients with drug-resistant tuberculosis treated with Clofazimine have body image disorder and stigma, and the two are positively correlated. Caregivers should carry out psychological assessment and intervention at an early stage to improve the patient′s mental health level.
